Chlorella ingestion in borderline diabetics: a double blind, placebo-controlled study and open study
- Conditions
- borderline diabetics
- Registration Number
- JPRN-UMIN000011446
- Lead Sponsor
- Sun Chlorella Corp.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 60
Not provided
1)BMI>30 2)Patient of the Diabetes or hypertension or hyperlipidemia. systolic blood pressure > 160 mmHg diastolic blood > 100 mmHg HbA1c > 7.4% LDL-Cholesterol > 190 mg/dL 3)These prescreened medicine. 4)These having Food for Specified Health Uses (FOSHU) and/or health food. 5)These having a history of serious diseases in metabolic and/or endocrine system. 6)Those that have extremely disheveled lifestyle and/or dietary habits. 7)Heavy alcohol drinker. 8)Those that are considered to be ineligible to participate to this test due to their abnormality at the screening test. 9)Diabetes or hypertension or hyperlipidemia patient who is NOT accompanied by obesity, but whose disease is attributed etiologically to hereditary factor or other non-obesity factors. 10)Those that are judged not applicable to this study by physicians. 11)The subject who takes warfarin. 12)Those participating in another trial or other investigational.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c,FFA, resistin gene expression and adipocytokine
- Secondary Outcome Measures
Name Time Method